RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Vida Ventures
V

Vida Ventures portfolio

Vida Ventures has 2 portfolio companies on record at Recent Funding. It led 1 of the 3 rounds it joined. Its most recent investment on record is Avalyn Pharma's $100M Series B+ round in September 2023, alongside Wellington Management, T. Rowe Price, TPG Biotech and 6 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with TCG Crossover, MPM Capital and Octagon Capital Advisors, most often TCG Crossover (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Rounds led: 1 of 3.
Capital in their rounds: $256M.
Latest deal: Avalyn Pharma · Sep 27, 2023.

What Vida Ventures invests in

Vida Ventures recent investments

How Vida Ventures invests

StageDealsCapital in rounds
Series A 2 67%$156M
Series B+ 1 33%$100M
YearDealsCapital in rounds
2021 1 33%$72M
2022 1 33%$84M
2023 1 33%$100M

Share is of the 3 rounds on Recent Funding that name Vida Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Vida Ventures portfolio companies

CompanyRound with Vida VenturesTotal raisedLatest raise
AAvalyn Pharma
Health and bio
Series B+ · $100M$135.5MSep 27, 2023
Series B+
AAktis Oncology
Health and bio
Series A · $84M$336MSep 1, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Vida Ventures, which is a subset of its real portfolio. API: /api/v1/investors/vida-ventures (get a free API key). More: the most active VC firms and new venture capital funds.